Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3849-3855
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3849
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3849
Table 1 Summarize the treatment of this case
Treatment mode | Starting and ending time | Efficacy |
Surgery | August 30, 2017 | Tumor resection; Disease progression |
Chemoradiotherapy | October, 2017-April, 2018 | Brain metastasis |
Targeted therapy (Cabozantinib) | May, 2018-April, 2020 | Organ metastases gradually shrink |
Immunotherapy (Nivolumab) | July, 2018- | Prolonged progression-free survival |
- Citation: Ma DX, Ding XP, Zhang C, Shi P. Combined targeted therapy and immunotherapy in anaplastic thyroid carcinoma with distant metastasis: A case report. World J Clin Cases 2022; 10(12): 3849-3855
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3849.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3849